• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国新诊断炎症性肠病的增加和预后的改善:一项来自单一中心的 30 年回顾性研究。

Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre.

机构信息

Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.

出版信息

BMC Gastroenterol. 2020 Nov 12;20(1):377. doi: 10.1186/s12876-020-01527-1.

DOI:10.1186/s12876-020-01527-1
PMID:33183228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7659043/
Abstract

BACKGROUND

We aimed to characterize the trends of prognosis in ulcerative colitis (UC) and Crohn's disease (CD) in a Chinese tertiary hospital.

METHODS

A 30-year retrospective cohort analysis was conducted at Peking Union Medical College Hospital. Consecutive patients newly diagnosed with UC or CD from 1985 to 2014 were included. The primary outcome was in-hospital mortality. The secondary outcomes included surgery and length of stay in hospital. The Pearson correlation coefficient was applied to determine the relationship between time and prognosis. Multivariable logistic regression analysis was performed to determine the risk factors for in-hospital mortality and surgery.

RESULTS

In total, 1467 patients were included in this study (898 cases with UC and 569 cases with CD). Annual admissions for UC and CD have increased significantly over the last 30 years (UC, r = 0.918, P < 0.05; CD, r = 0.898, P < 0.05). Decreased in-hospital mortality was observed both in patients with UC and CD (UC, from 2.44 to 0.27%, r = - 0.827, P < 0.05; CD, from 12.50 to 0.00%, r = - 0.978, P < 0.05). A decreasing surgery rate was observed in patients with CD (r = - 0.847, P < 0.05), while an increasing surgery rate was observed in patients with UC (r = 0.956, P < 0.05). Shortened average lengths of hospital stay were observed in both UC and CD patients (UC, from 47.83 ± 34.35 to 23.58 ± 20.05 days, r = - 0.970, P < 0.05; CD, from 65.50 ± 50.57 to 26.41 ± 18.43 days, r = - 0.913, P < 0.05). Toxic megacolon and septic shock were independent risk factors for in-hospital mortality in patients with UC. Intestinal fistula and intestinal perforation were independent risk factors for in-hospital mortality in patients with CD.

CONCLUSIONS

In this cohort, the admissions of patients with UC and CD were increased, with significantly improved prognoses during the past 30 years.

摘要

背景

我们旨在描述中国一家三级医院溃疡性结肠炎(UC)和克罗恩病(CD)患者的预后趋势。

方法

本研究为北京协和医学院医院的一项 30 年回顾性队列分析。纳入 1985 年至 2014 年期间新诊断为 UC 或 CD 的连续患者。主要结局为住院死亡率。次要结局包括手术和住院时间。采用 Pearson 相关系数确定时间与预后之间的关系。采用多变量逻辑回归分析确定住院死亡率和手术的危险因素。

结果

本研究共纳入 1467 例患者(UC 898 例,CD 569 例)。过去 30 年,UC 和 CD 的年住院人数均显著增加(UC,r=0.918,P<0.05;CD,r=0.898,P<0.05)。UC 和 CD 患者的住院死亡率均呈下降趋势(UC,从 2.44%降至 0.27%,r=-0.827,P<0.05;CD,从 12.50%降至 0.00%,r=-0.978,P<0.05)。CD 患者的手术率呈下降趋势(r=-0.847,P<0.05),UC 患者的手术率呈上升趋势(r=0.956,P<0.05)。UC 和 CD 患者的平均住院时间均缩短(UC,从 47.83±34.35 天缩短至 23.58±20.05 天,r=-0.970,P<0.05;CD,从 65.50±50.57 天缩短至 26.41±18.43 天,r=-0.913,P<0.05)。中毒性巨结肠和感染性休克是 UC 患者住院死亡率的独立危险因素。肠瘘和肠穿孔是 CD 患者住院死亡率的独立危险因素。

结论

在本队列中,UC 和 CD 患者的入院人数增加,在过去 30 年中,预后明显改善。

相似文献

1
Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre.中国新诊断炎症性肠病的增加和预后的改善:一项来自单一中心的 30 年回顾性研究。
BMC Gastroenterol. 2020 Nov 12;20(1):377. doi: 10.1186/s12876-020-01527-1.
2
Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.埃及开罗炎症性肠病的流行病学和临床特征
World J Gastroenterol. 2014 Jan 21;20(3):814-21. doi: 10.3748/wjg.v20.i3.814.
3
A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.一项针对马来西亚吉隆坡单一三级医疗中心炎症性肠病患者发病率趋势、社会人口学和临床特征的四十年分析。
BMC Public Health. 2019 Jun 13;19(Suppl 4):550. doi: 10.1186/s12889-019-6858-2.
4
[Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias].[阿斯图里亚斯希洪市慢性炎症性肠病的流行病学]
Gastroenterol Hepatol. 2001 May;24(5):228-35.
5
Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.对中国中部武汉市452例炎症性肠病患者进行的回顾性调查。
Inflamm Bowel Dis. 2006 Mar;12(3):212-7. doi: 10.1097/01.MIB.0000201098.26450.ae.
6
[Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].[2000年至2014年期间184例炎症性肠病患儿的单中心回顾性研究]
Zhonghua Er Ke Za Zhi. 2017 Jul 2;55(7):493-498. doi: 10.3760/cma.j.issn.0578-1310.2017.07.005.
7
Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.1997 年至 2009 年美国儿童炎症性肠病住院和手术肠道切除的全国时间趋势。
Inflamm Bowel Dis. 2013 Oct;19(11):2423-32. doi: 10.1097/MIB.0b013e3182a56148.
8
Increasing thirty-day readmissions of Crohn's disease and ulcerative colitis in the United States: A national dilemma.美国克罗恩病和溃疡性结肠炎30天再入院率上升:一个全国性难题。
World J Gastrointest Pathophysiol. 2022 May 22;13(3):85-95. doi: 10.4291/wjgp.v13.i3.85.
9
Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.斯里兰卡炎症性肠病的表型变化、早期临床病程及临床预测因素:一项基于三级医疗的回顾性多中心研究
BMC Gastroenterol. 2021 Feb 16;21(1):71. doi: 10.1186/s12876-021-01644-5.
10
Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease.炎症性肠病穿孔的发病机制、发病率及结局的差异
Surg Gynecol Obstet. 1985 Jan;160(1):63-9.

引用本文的文献

1
Global disease burden of inflammatory bowel disease in women and women of childbearing age from 1990 to 2021 and its prediction to 2040.1990年至2021年女性及育龄期女性炎症性肠病的全球疾病负担及其至2040年的预测。
PLoS One. 2025 Sep 10;20(9):e0331034. doi: 10.1371/journal.pone.0331034. eCollection 2025.
2
Growing burden of inflammatory bowel disease in China: Findings from the Global Burden of Disease Study 2021 and predictions to 2035.中国炎症性肠病负担日益加重:2021年全球疾病负担研究结果及至2035年的预测
Chin Med J (Engl). 2024 Dec 5;137(23):2851-2859. doi: 10.1097/CM9.0000000000003345. Epub 2024 Nov 6.
3
Clinical Features of Crohn's Disease Stratified by Age at Diagnosis According to Montreal Classification.根据蒙特利尔分类法按诊断年龄分层的克罗恩病临床特征
J Inflamm Res. 2023 Feb 21;16:737-746. doi: 10.2147/JIR.S397483. eCollection 2023.
4
Efficacy and Safety of Bifidobacterium Quadruple Viable Bacteria Combined with Mesalamine against UC Management: A Systematic Review and Meta-Analysis.双歧四联活菌联合美沙拉嗪治疗溃疡性结肠炎的疗效及安全性:系统评价和 Meta 分析。
Oxid Med Cell Longev. 2022 Oct 4;2022:8272371. doi: 10.1155/2022/8272371. eCollection 2022.
5
Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019.中国三十年来炎症性肠病负担的长期趋势:基于 GBD 2019 的联合回归和年龄-时期-队列分析。
Front Public Health. 2022 Sep 7;10:994619. doi: 10.3389/fpubh.2022.994619. eCollection 2022.
6
Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis.COVID-19 大流行期间炎症性肠病患者的远程监测-成本效益分析。
PLoS One. 2022 Apr 7;17(4):e0266464. doi: 10.1371/journal.pone.0266464. eCollection 2022.
7
Correction to: Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre.对《中国新诊断炎症性肠病的增加及预后改善:一项来自单中心的30年回顾性研究》的更正
BMC Gastroenterol. 2022 Mar 8;22(1):109. doi: 10.1186/s12876-021-02077-w.
8
Alterations of Regional Homogeneity in Crohn's Disease With Psychological Disorders: A Resting-State fMRI Study.克罗恩病伴心理障碍患者局部一致性的改变:一项静息态功能磁共振成像研究
Front Neurol. 2022 Feb 2;13:817556. doi: 10.3389/fneur.2022.817556. eCollection 2022.

本文引用的文献

1
A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease.炎症性肠病发病机制的全面综述和更新。
J Immunol Res. 2019 Dec 1;2019:7247238. doi: 10.1155/2019/7247238. eCollection 2019.
2
Reliability of standardized reporting system of acute appendicitis in adults at low-dose 320-rows CT.低剂量320排CT对成人急性阑尾炎标准化报告系统的可靠性
Eur J Radiol Open. 2019 Nov 14;6:330-335. doi: 10.1016/j.ejro.2019.11.001. eCollection 2019.
3
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.炎症性肠病在西方国家和新兴工业化国家住院率的变化趋势:经济合作与发展组织国家的一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295. doi: 10.1016/S2468-1253(19)30013-5. Epub 2019 Feb 12.
4
Diagnostic Value of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient in Assessment of the Activity of Crohn Disease: 1.5 or 3 T.扩散加权成像及表观扩散系数在评估克罗恩病活动度中的诊断价值:1.5T或3T
J Comput Assist Tomogr. 2018 Sep/Oct;42(5):688-696. doi: 10.1097/RCT.0000000000000754.
5
Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.克罗恩病的手术率正在下降:一项基于人群的时间趋势分析与验证研究
Am J Gastroenterol. 2017 Dec;112(12):1840-1848. doi: 10.1038/ajg.2017.394. Epub 2017 Oct 31.
6
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
7
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.香港炎症性肠病患者确诊后最初 2 年内的直接医疗保健成本利用情况。
J Gastroenterol Hepatol. 2018 Jan;33(1):141-149. doi: 10.1111/jgh.13817.
8
What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease?我们能从炎症性肠病的流行病学研究中学到什么?
Dig Dis. 2017;35(1-2):69-73. doi: 10.1159/000449086. Epub 2017 Feb 1.
9
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.了解和预防炎症性肠病的全球增长。
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.
10
Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO.新疗法对炎症性肠病住院、手术、感染及死亡率的影响:欧洲克罗恩病和结肠炎组织(ECCO)流行病学委员会的重点论文
J Crohns Colitis. 2016 Feb;10(2):216-25. doi: 10.1093/ecco-jcc/jjv190. Epub 2015 Oct 31.